Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 20, Issue 12, Pages 1591-1609Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543784.2011.627853
Keywords
adenosine receptors; cancer; cardiovascular diseases; health; inflammation; neurological diseases; respiratory disorders
Categories
Ask authors/readers for more resources
Introduction: The adenosine receptors A(1), A(2A), A(2B) and A(3) are important and ubiquitous mediators of cellular signaling that play vital roles in protecting tissues and organs from damage. In particular, adenosine triggers tissue protection and repair by different receptor-mediated mechanisms, including increasing the oxygen supply: demand ratio, pre-conditioning, anti-inflammatory effects and the stimulation of angiogenesis. Areas covered: The state of the art of the role of adenosine receptors which have been proposed as targets for drug design and discovery, in health and disease, and an overview of the ligands for these receptors in clinical development. Expert opinion: Selective ligands of A(1), A(2A), A(2B) and A(3) adenosine receptors are likely to find applications in the treatment of pain, ischemic conditions, glaucoma, asthma, arthritis, cancer and other disorders in which inflammation is a feature. The aim of this review is to provide an overview of the present knowledge regarding the role of these adenosine receptors in health and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available